$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 8.01 Accession Number: 0001683168-22-005917 Act: 34 Size: 202 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 8.01 Accession Number: 0001683168-22-005841 Act: 34 Size: 199 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-22-005667 Act: 34 Size: 236 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-22-005637 Act: 34 Size: 2 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 8.01 Accession Number: 0001683168-22-005343 Act: 34 Size: 199 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 8.01 Accession Number: 0001683168-22-005181 Act: 34 Size: 198 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-22-004817 Act: 34 Size: 275 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ PRE 14A Other preliminary proxy statements Accession Number: 0001683168-22-004577 Act: 34 Size: 275 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-22-003687 Act: 34 Size: 237 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-22-003588 Act: 34 Size: 2 MB 网页链接